Fair Value Measurements - Narrative (Details) - USD ($) $ in Thousands	1 Months Ended	9 Months Ended
	Jul. 31, 2025	Sep. 30, 2025	Sep. 30, 2024
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Proceeds from securities purchase agreement equity issuance		$ 50,000	$ 0
Equity issued for contingent consideration		$ 5,894	$ 0
ImmPACT Bio USA Inc.
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent consideration, shares issued (in shares)	625,000
Equity issued for contingent consideration	$ 5,900
Securities Purchase Agreement
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Proceeds from securities purchase agreement equity issuance	50,000
Sale of stock, shares required to purchase by purchaser	$ 50,000